SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA inspects Alkem Laboratories’ Bioequivalence facility at Taloja

15 Jul 2017 Evaluate

The US Food and Drug Administration (USFDA) has conducted an inspection at Alkem Laboratories’ Bioequivalence facility located at Taloja in state of Maharashtra from July 10, 2017 to July 14, 2017. At the end of the inspection, no Form 483 was issued.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

5641.00 57.30 (1.03%)
20-Apr-2026 15:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.30
Dr. Reddys Lab 1234.00
Cipla 1231.50
Zydus Lifesciences 937.50
Lupin 2329.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×